
The New York Times recently painted a disturbing picture of Elon Musk’s drug habits. Although the Wall Street Journal has previously reported on these practices, the NYT investigation claims that the scale of the billionaire’s consumption is far greater than previously assumed, or than he himself has acknowledged.
In public, Elon Musk was rising to political power as one of President Trump’s key allies. In private, Musk was taking drugs and facing an increasingly turbulent family life amid overlapping romantic relationships and legal battles over his children. Read more: nyti.ms/4mDTEVr
— The New York Times (@nytimes.com) 2025-05-30T11:22:27.348Z
While he claimed to treat his “negative moods” only with small doses of ketamine, about once every two weeks in his own words, several observers pointed to public appearances where Elon Musk seemed visibly under the influence of drugs.

One of the most talked-about examples remains his presence at Donald Trump’s inauguration, where he was filmed staring at the ceiling, head and eyes swirling, a behavior interpreted by many as evidence of increased consumption, just as he was in the president’s direct orbit.

But the New York Times goes further, claiming that Elon Musk’s ketamine consumption, which he publicly downplayed, would have become so extensive that it would have led to medical complications.

While Elon Musk’s behavior at several political events has fueled suspicions of possible drug use, these allegations are based on behavior deemed erratic at official meetings or public appearances. Musk, for his part, has categorically denied these accusations.
Now that he’s back in business full-time, forsaking politics for the time being at least, will these allegations of drug abuse have an impact on Elon Musk’s future?